Kevin R. Webster - Concepedia

Author

Kevin R. Webster

Bristol-Myers Squibb (United States)ORCID

Also Known As

K R Webster, K. Webster, K.R. Webster, Kevin R Webster, Kevin R. Webster, Kevin Webster, Webster, Kevin, Webster, Kevin R.

Publications

2.8K

Citations

H-Index

Concepts

All Affiliations

Bristol-Myers Squibb (United States)Bristol-Myers Squibb (Germany)Yale University The University of Texas MD Anderson Cancer Center Frontier Medicines (United States)

About

Kevin R. Webster is an author at Bristol-Myers Squibb (United States) specializing in medicine, tumor biology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	18	1.6K
2	Natural Sciences	7	7	731
3	Engineering	2	2	33
4	Health Sciences	1	1	251
5	Allergy	1	1	19

Kevin R. Webster

Publications

2.6K

Citations

H-Index

Page 1

	Year	Citations
Abnormal expression of the cell cycle regulators P16 and CDK4 in Alzheimer's disease. Andrew McShea, Peggy L.R. Harris, Kevin R. Webster, PubMed	1997	431
p53 is associated with cellular microtubules and is transported to the nucleus by dynein Paraskevi Giannakakou, Dan L. Sackett, Yvona Ward, Nature Cell Biology Cellular MicrotubulesNatural SciencesCell InteractionMolecular BiologyCell Motility	2000	360
Translation control of the immune checkpoint in cancer and its therapeutic targeting Yichen Xu, Mauro Poggio, Hyun Yong Jin, Nature Medicine Immune CheckpointTumor BiologyCancer ImmunosurveillanceMedicineImmunology	2019	256
<i>N</i>-(Cycloalkylamino)acyl-2-aminothiazole Inhibitors of Cyclin-Dependent Kinase 2. <i>N</i>-[5-[[[5-(1,1-Dimethylethyl)-2-oxazolyl]methyl]thio]-2-thiazolyl]-4- piperidinecarboxamide (BMS-387032), a Highly Efficacious and Selective Antitumor Agent Raj N. Misra, Hai‐Yun Xiao, Kyoung S. Kim, Journal of Medicinal Chemistry Chemoprevention StrategyImmunologyPharmacotherapyCdk2/cyce IcPharmaceutical Chemistry	2004	251
Structure-based Design of Pyridone–Aminal eFT508 Targeting Dysregulated Translation by Selective Mitogen-activated Protein Kinase Interacting Kinases 1 and 2 (MNK1/2) Inhibition Siegfried Reich, Paul A. Sprengeler, Gary G. Chiang, Journal of Medicinal Chemistry Drug TargetMrna TranslationMolecular BiologyCancer BiologyTumor Biology	2018	169
Discovery of Aminothiazole Inhibitors of Cyclin-Dependent Kinase 2: Synthesis, X-ray Crystallographic Analysis, and Biological Activities Kyoung Soon Kim, S. David Kimball, Raj N. Misra, Journal of Medicinal Chemistry Combinatorial ChemistryDrug TargetCdk2 ProteinCompound 14Heterocycle Chemistry	2002	156
Design of Development Candidate eFT226, a First in Class Inhibitor of Eukaryotic Initiation Factor 4A RNA Helicase Justin T. Ernst, Peggy A. Thompson, Christian Nilewski, Journal of Medicinal Chemistry	2020	135
Nociceptor Translational Profiling Reveals the Ragulator-Rag GTPase Complex as a Critical Generator of Neuropathic Pain Salim Megat, Pradipta Ray, Jamie K. Moy, Journal of Neuroscience	2018	133
Identification of CDK4 Sequences Involved in Cyclin D1 and p16 Binding Kevin Coleman, Barri Wautlet, Janet G. Mulheron, Journal of Biological Chemistry	1997	98
Thio- and Oxoflavopiridols, Cyclin-Dependent Kinase 1-Selective Inhibitors: Synthesis and Biological Effects Kyoung Soon Kim, John S. Sack, John S. Tokarski, Journal of Medicinal Chemistry Flavopiridol AnaloguesPharmacotherapyChemical BiologyPharmaceutical ChemistryMolecular Pharmacology	2000	96

Page 1